DREAMCIS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,680 KRW | -6.36% |
|
-12.80% | +13.06% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 38.87B 28.77M | Sales 2023 | 47.84B 35.4M | Capitalization | 75.04B 55.53M |
|---|---|---|---|---|---|
| Net income 2022 | 4.4B 3.26M | Net income 2023 | 3.74B 2.77M | EV / Sales 2022 | 1.13 x |
| Net cash position 2022 | 17.56B 12.99M | Net cash position 2023 | 16.79B 12.42M | EV / Sales 2023 | 1.22 x |
| P/E ratio 2022 |
13.8
x | P/E ratio 2023 |
20.8
x | Employees | 236 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.16% |
More Fundamentals
* Assessed data
More news
| 1 day | -6.36% | ||
| 1 week | -12.80% | ||
| Current month | +22.26% | ||
| 1 month | +35.05% | ||
| 3 months | +21.25% | ||
| 6 months | +2.79% | ||
| Current year | +13.06% |
1 week
3 655.00
4 285.00
1 month
2 670.004 600.00
Current year
2 610.004 600.00
1 year
2 610.009 750.00
3 years
2 370.009 750.00
5 years
2 370.009 750.00
10 years
2 370.009 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kyung-Sun Gong
CEO | Chief Executive Officer | 56 | - |
Nam-Hoon Kim
BRD | Director/Board Member | 43 | - |
Tae-Sik Yang
DFI | Director of Finance/CFO | 55 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 3,680 | -6.36% | 658,272 |
| 24-05-16 | 3,930 | -7.53% | 928,709 |
| 24-05-14 | 4,250 | +0.71% | 397,997 |
| 24-05-13 | 4,220 | 0.00% | 291,471 |
| 24-05-10 | 4,220 | +0.36% | 616,864 |
End-of-day quote Korea S.E., May 16, 2024
More quotes
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
Calendar
2024-08-08
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.06% | 64.48M | |
| -16.99% | 8.55B | |
| +65.23% | 4.24B | |
| -1.63% | 2.54B | |
| -41.76% | 2.35B | |
| -8.53% | 1.89B | |
| -19.29% | 1.55B | |
| -39.61% | 1.23B | |
| +9.54% | 1.13B | |
| +19.57% | 955M |
- Stock Market
- Equities
- A223250 Stock
